hydrochlorothiazide has been researched along with isradipine in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (15.79) | 18.7374 |
1990's | 26 (68.42) | 18.2507 |
2000's | 3 (7.89) | 29.6817 |
2010's | 3 (7.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bond, MG; Borhani, NO; Brugger, SB; Craven, TE; Flack, J; Khoury, S; Miller, ST; Schnaper, HW | 1 |
McGrath, BP; McNeil, JJ; Silagy, CA | 1 |
Borhani, NO; Brugger, SB; Byington, RP | 1 |
Bannatyne, RE; Lopez, L; Matthews, K; McCarley, D; Quay, G; Stein, GH | 1 |
Bond, MG; Borhani, NO; Buckalew, V; Canossa-Terris, M; Gibbons, ME; Sowers, JR; Worthy, AJ | 1 |
Gaube, S; Gisinger, C; Klauser, R; Küenburg, E; Prager, R; Schernthaner, G; Schnack, C | 1 |
Applegate, WB; Byington, RP | 1 |
Samuel, P | 1 |
Abrams, A; Cutler, R; Hamilton, B; Holtzman, JL; Kirkendall, WM; Matthews, KP; Neri, G; Stein, GH | 1 |
Bond, G; Brugger, S; Byington, R; Flack, JM; Grimm, RH | 1 |
Bond, MG; Enevold, GL; Strickland, HL; Wilmoth, SK | 1 |
Borhani, NA; Byington, RP; Furberg, CD | 1 |
Carr, AA; Gonasun, LM; Nelson, EB; Prisant, LM; Velasquez, MT; Winer, N | 1 |
Hamilton, BP | 1 |
Gonasun, LM; Goodman, RP; Kirkendal, WM; Kontos, HA; Mohanty, PK; Samuel, P; Wright, JT | 1 |
Chin, B; Gonasun, LM; Kirkendall, W; Lieberman, S; Samuel, P; Schaefer, EJ; Schoenfeld, BH | 1 |
Hansson, L; Zanchetti, A | 1 |
Abrams, A; Culter, R; Hamilton, BP; Hamilton, JH; Holtzman, JL; Kirkendall, WM; Matthews, K; Neri, G; Stein, GH | 1 |
Borhani, NO | 1 |
Amery, A; Bielen, E; Fagard, R; Staessen, J; Thijs, L | 1 |
Bartels, DW; Benz, JR; Due, DL; Hall, WD; Kostis, JB; Peng, A; Perry, HM; Sirgo, M; Townsend, RR | 1 |
Bond, MG; Carr, AA; Nichols, FT; Prisant, LM; Sowers, JR; Thompson, WO; Zemel, MB; Zemel, PC | 1 |
Borhani, NO; Byington, RP; Furberg, CD; Gibbons, ME; Sowers, JR | 1 |
Bond, MG; Borhani, NO; Borhani, PA; Buckalew, VM; Canossa-Terris, M; Carr, AA; Kappagoda, T; Mercuri, M; Rocco, MV; Schnaper, HW; Sowers, JR | 1 |
Madren, EM | 1 |
Chase, GA; Cushman, WG; Gottdiener, JS; Gottdiener, PS; Narayan, P; Papademetriou, V; Zachariah, PK | 1 |
Furberg, CD; Pahor, M; Psaty, BM | 1 |
Aalkjaer, C; Lederballe, O; Mulvany, MJ; Schroeder, AP; Sihm, I; Thygesen, K | 1 |
Hietanen, EK; Kantola, IM; Kataja, MJ; Pelttari, LH; Salo, TT | 1 |
Byington, RP; Craven, TE; Furberg, CD; Pahor, M; Sowers, JR | 1 |
Byington, RP; Craven, TE; Furberg, CD; Pahor, M | 1 |
Kantola, I; Pelttari, L; Salo, TM; Viikari, JS; Voipio-Pulkki, LM | 1 |
1 review(s) available for hydrochlorothiazide and isradipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
28 trial(s) available for hydrochlorothiazide and isradipine
Article | Year |
---|---|
MIDAS: hypertension and atherosclerosis. A trial of the effects of antihypertensive drug treatment on atherosclerosis. MIDAS Research Group.
Topics: Antihypertensive Agents; Arteriosclerosis; Dihydropyridines; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male | 1992 |
Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitors; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male | 1992 |
Multicenter study with isradipine and diuretics against atherosclerosis. US MIDAS Research Group.
Topics: Arteriosclerosis; Calcium Channel Blockers; Carotid Artery Diseases; Coronary Artery Disease; Diuretics; Electrocardiography; Humans; Hydrochlorothiazide; Insulin; Isradipine; Multicenter Studies as Topic; Pyridines; Quality of Life; Randomized Controlled Trials as Topic; Regional Blood Flow; Research Design | 1990 |
The Multicenter Isradipine/Diuretic Atherosclerosis Study: a study of the antiatherogenic properties of isradipine in hypertensive patients. MIDAS Research Group.
Topics: Adult; Aged; Arteriosclerosis; Calcium Channel Blockers; Carotid Arteries; Dihydropyridines; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Middle Aged; Ultrasonography | 1991 |
Metabolic effects of isradipine versus hydrochlorothiazide in diabetes mellitus.
Topics: Adult; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucose; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Insulin; Insulin Resistance; Insulin Secretion; Isradipine; Male; Middle Aged; Pyridines | 1991 |
MIDAS, the Multicenter Isradipine/Diuretic Atherosclerosis Study. Design features and baseline data.
Topics: Adult; Aged; Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Carotid Arteries; Diuretics; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Middle Aged; Pyridines; Sodium Chloride Symporter Inhibitors; Ultrasonography | 1991 |
Effect of isradipine, a new calcium antagonist on the lipid profile in patients with hypertension.
Topics: Antihypertensive Agents; Apolipoproteins; Calcium Channel Blockers; Cholesterol; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Lipids; Male; Middle Aged; Pyridines; Randomized Controlled Trials as Topic | 1990 |
Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Middle Aged; Pyridines; Sodium | 1990 |
A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS).
Topics: Adult; Antihypertensive Agents; Arteriosclerosis; Carotid Artery Diseases; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Isradipine; Male; Middle Aged; Pyridines | 1990 |
Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research Group.
Topics: Adult; Antihypertensive Agents; Arteriosclerosis; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Multicenter Studies as Topic; Pyridines; Random Allocation; Risk Factors; Ultrasonography | 1989 |
Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Middle Aged; Multicenter Studies as Topic; Propranolol; Pyridines; Randomized Controlled Trials as Topic | 1989 |
Treatment of essential hypertension with PN 200-110 (isradipine).
Topics: Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Middle Aged; Oxadiazoles; Prazosin; Propranolol; Random Allocation; Time Factors | 1987 |
Isradipine (PN 200-110) versus hydrochlorothiazide in mild to moderate hypertension. A multicenter study.
Topics: Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Pyridines | 1988 |
Effects of isradipine, a new calcium antagonist, versus hydrochlorothiazide on serum lipids and apolipoproteins in patients with systemic hypertension.
Topics: Adult; Aged; Apolipoproteins; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Lipids; Male; Middle Aged; Multicenter Studies as Topic; Pyridines; Random Allocation; Time Factors | 1988 |
The antiatherosclerotic effect of calcium antagonists in man--what did MIDAS actually show? Multicenter Isradipine Diuretic Atherosclerosis Study.
Topics: Arteriosclerosis; Carotid Arteries; Controlled Clinical Trials as Topic; Humans; Hydrochlorothiazide; Isradipine; Ultrasonography | 1995 |
One year experience of elderly hypertensive patients with isradipine therapy.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Middle Aged; Patient Dropouts | 1994 |
MIDAS: rationale, design and descriptive data of trial patients. The MIDAS Research Group.
Topics: Adult; Aged; Arteriosclerosis; Carotid Arteries; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Middle Aged; Reproducibility of Results; Research Design; Tunica Intima; Tunica Media; Ultrasonography | 1994 |
Response of ambulatory blood pressure to antihypertensive therapy guided by clinic pressure.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitors; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Lisinopril; Male; Prospective Studies | 1993 |
Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women.
Topics: Aged; Atenolol; Blood Pressure; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Middle Aged; Potassium; Prospective Studies | 1994 |
Carotid plaque associations among hypertensive patients.
Topics: Aged; Arteriosclerosis; Carotid Stenosis; Female; Georgia; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Michigan; Middle Aged; Risk Factors; Ultrasonography | 1993 |
Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study.
Topics: Adult; Aged; Arteriosclerosis; Carotid Arteries; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Middle Aged; Treatment Outcome; Ultrasonography | 1993 |
Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial.
Topics: Aged; Antihypertensive Agents; Arteriosclerosis; Carotid Arteries; Diastole; Disease Progression; Diuretics; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Isradipine; Likelihood Functions; Male; Middle Aged; Regression Analysis; Sodium Chloride Symporter Inhibitors; Systole; Treatment Outcome; Tunica Intima; Ultrasonography; Vasodilator Agents | 1996 |
Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Double-Blind Method; Echocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Isradipine; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Time Factors | 1997 |
Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.
Topics: Adult; Amiloride; Antihypertensive Agents; Arteries; Buttocks; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Middle Aged; Myocardium; Sodium Chloride Symporter Inhibitors | 1998 |
Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Diuretics; Double-Blind Method; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Middle Aged; Sleep Apnea Syndromes; Sodium Chloride Symporter Inhibitors; Treatment Failure | 1998 |
Isradipine in prediabetic hypertensive subjects.
Topics: Antihypertensive Agents; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Coronary Disease; Diabetic Angiopathies; Double-Blind Method; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Insulin; Isradipine; Male; Prediabetic State; Time Factors | 1998 |
Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events.
Topics: Arteriosclerosis; Blood Glucose; Calcium Channel Blockers; Cardiovascular Diseases; Carotid Artery Diseases; Diuretics; Glucose Intolerance; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Middle Aged; Risk Factors; Sodium Chloride Symporter Inhibitors | 1997 |
The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients--assessment by spectral analysis of heart rate and blood pressure variability.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Autonomic Nervous System; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Enalapril; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Middle Aged; Sleep Apnea Syndromes; Sodium Chloride Symporter Inhibitors | 1999 |
9 other study(ies) available for hydrochlorothiazide and isradipine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Long-term lipid profiles with isradipine and hydrochlorothiazide treatment in elderly hypertensive patients.
Topics: Aged; Aged, 80 and over; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Lipids; Male; Middle Aged; Prospective Studies; Pyridines | 1990 |
Detection and monitoring of asymptomatic atherosclerosis in clinical trials.
Topics: Antihypertensive Agents; Arteriosclerosis; Calcium Channel Blockers; Carotid Arteries; Humans; Hydrochlorothiazide; Hypertension; Image Processing, Computer-Assisted; Isradipine; Monitoring, Physiologic; Pyridines; Ultrasonography | 1989 |
Vascular events during antihypertensive treatment.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Carotid Stenosis; Diuretics; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Randomized Controlled Trials as Topic; Reproducibility of Results; Sodium Chloride Symporter Inhibitors | 1996 |
Treatment of hypertensive patients with diabetes.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Case-Control Studies; Cohort Studies; Diabetes Complications; Enalapril; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Nisoldipine; Randomized Controlled Trials as Topic | 1998 |